The week in health tech, explained in plain English.Get the free newsletter →
October 25, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Government

ARPA-H Backs Kaiser, Duke for $62.7M Autonomous AI Push

By Healthcare Technology News ·

ARPA-H is betting on autonomous AI for heart care. The federal health research agency announced Sept. 9 that it selected six teams, including Kaiser Permanente and Duke, to build the first FDA-authorized agentic AI system for cardiovascular care, according to Becker's Hospital Review.

The program, named Agentic AI-EnableD CardioVascular CAre TransfOrmation, or ADVOCATE, runs four years and carries a $62.7 million budget, with up to $33.7 million available in year one. The goal is agentic AI: systems that take actions and manage care workflows autonomously rather than simply flagging findings for a clinician to review.

The effort matters because most healthcare AI cleared to date is assistive, keeping a human in the loop. Pushing toward FDA authorization for autonomous agents in a high-stakes specialty like cardiology would set a regulatory and clinical precedent. Cardiovascular disease remains the leading cause of death in the US, making it a logical, high-volume proving ground for whether agentic AI can operate safely at scale.

Sources

More in Government

Government

HHS Launches National Plan to Overhaul US Kidney Care

HHS launched a national kidney care plan centered on prevention, dialysis reform with more patient choice, and overhauling the transplant system.

Why it matters: Kidney disease affects 1 in 7 US adults and drives major Medicare spending, so federal direction here reshapes care models and markets.

Government

FDA Approves First Once-Weekly Insulin for Children

The FDA approved Novo Nordisk's Awiqli, the first once-weekly basal insulin for children 10 and older with Type 2 diabetes.

Why it matters: Weekly rather than daily insulin could improve adherence for a growing number of children with Type 2 diabetes.

Government

Feds Launch False Claims Act Self-Disclosure Pilot

HHS and the DOJ Civil Division have launched a six-month pilot letting healthcare companies self-report potential civil False Claims Act violations and settle through a coordinated civil release.

Why it matters: The pilot reshapes how hospitals and healthcare firms weigh self-reporting against federal fraud enforcement, with real consequences for compliance strategy.